<- Go Home
SmithKline Beecham Limited
SmithKline Beecham Limited manufactures and sells vaccines and pharmaceutical products. It offers prescription, over-the counter medicines, animal health, and nutritional products. SmithKline Beecham Limited was formerly known as SmithKline Beecham Plc and changed its name to SmithKline Beecham Limited in October 2009. The company was incorporated in 1989 and is based in Brentford, United Kingdom. SmithKline Beecham Limited operates as a subsidiary of GlaxoSmithKline Finance plc.
Market Cap
$45.6B
Volume
638.1K
Cash and Equivalents
N/A
EBITDA
$2.3B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$6.4B
Profit Margin
76.12%
52 Week High
$48.61
52 Week Low
$35.47
Dividend
N/A
Price / Book Value
16.99
Price / Earnings
37.58
Price / Tangible Book Value
27.08
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$1.9B
Return on Equity
38.66%
Return on Assets
13.37
Cash and Short Term Investments
$361.0M
Debt
$1.4B
Equity
$3.9B
Revenue
$8.5B
Unlevered FCF
$747.8M
Sector
Pharmaceuticals
Category
N/A